Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Hydryllin is an oral syrup used primarily for the relief of cough, wheezing, chest congestion, and symptoms associated with asthma, bronchitis, and emphysema. It is a combination drug containing aminophylline (a bronchodilator that relaxes bronchial smooth muscle), diphenhydramine (an antihistamine that antagonizes histamine H1 receptors to reduce allergic reactions), ammonium chloride (an expectorant that helps loosen mucus), and menthol (which soothes the throat). The combined action of these ingredients provides symptomatic relief by opening airways, reducing allergic responses, thinning mucus for easier expulsion, and soothing irritated mucous membranes[3][4][5][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Hydryllin.